Publications

Jeonghoon Ahn
Jason Doctor
Joel Hay
Kathleen Johnson
Jeff McCombs
Mike Nichol

Jeonghoon Ahn

Mullins, C.D., Sikirica, M., Seneviratne, V., Ahn, J., Akhras, K.S. 2003. Multi–Country Comparison of Hypertension Costs from Hospitalizations and Ambulatory Care. Forthcoming on Pharmacoeconomics.

Klingman, D., Williams, S.A., Smith, T.W., Ahn, J., Prasad, C., O'Donnell, J.C. 2004. Correlates of Elevated C–Reactive Protein among Adults in the United States: Findings from the 1999–2000 National Health and Nutrition Examination Survey (in press).

Klingman, D., Williams, S.A., Benner, J.S., Smith, T.W., Ahn, J., O'Donnell, J.C. 2004. New Perspectives on the Dyslipidemia Treatment Gap from the 1999–2000 National Health and Nutrition Examination Survey (in press).

Yu, Y.F., Ahn, J., Yu A.P., Nichol, M.B. 2004 Rx Outcomes Research of Chronic Overactive Bladder: Medication Persistence and Refill Adherence of Overactive Bladder/Urinary Incontinence in the California Medicaid Program (in press).

Jason Doctor

Kahn JM, Doctor JN, Rubenfeld GD. Stress ulcer prophlaxis in mechanically ventilated patients: integrating evidence and judgment using a decision analysis. Intensive Care Medicine 2006, {Epub ahead of print}.

Sox CM, Koepsell TD, Doctor JN, Christakis DA. Pediatricians' clinical decision making: results of two randomized controlled trials of decisions support. Arch Ped and Adol Med 2006; 160,487-492.

Doctor JN, Miyamoto JM. Person tradeoffs and the problem of risk. Expert Reviews in Pharmacoeconomics & Outcome Research 2005;5,667-682.

Doctor JN, Castro J, Temkin NR, Fraser RT, Machamer JE, Dikmen SS. Workers' risk of unemployment after traumatic brain injury: a normed comparison. J International Neuropsychological Society 2005; 11,1-6.

Bleichrodt H, Doctor J, Stolk E. Equity weighting QALYs:the rank dependent QALY model. J Health Economics 2005; 24,655-678.

Doctor JN, Bleichrodt H, Miyamoto JM, Temkin NR, Dikem SS. A new and more robust test of QALYs. J Health Economics 2004; 23,353-367.

Doctor JN, Miyamoto JM. Deriving quality-adjusted life years (QALYs) from constant proportional time trade and risk posture conditions. J Mathematical Psychology 2003; 47,557-567.

Joel Hay

Chiou C–F; Hay J; Wallace J, Bloom B; Neumann P, Sullivan S, Yu H–T, Keeler E, Henning J, Ofman J. Development and Validation of A Grading System for the Quality of Cost–Effectiveness Studies. Medical Care 2003; 41:32–44.

Yuan Y, Hay J, McCombs J. Mortality and Hospitalization Impacts Of Pharmacy Consultation In Ambulatory Care. American Journal of Managed Care. 2003; 9(1):101–112.

Ofman J, Sullivan S, Neumann P, Chiou C–F, Henning J, Hay J. Examining The Value and Quality of Health Economic Analyses: Implications of Utilizing The QHES. Journal of Managed Care Pharmacy, 2003; 9(1):53–62.

Forrest S, Goetghebeur M, Hay J. "Understanding the Underlying Drivers of Inpatient Cost Growth: A Literature Review. American Journal of Managed Care. 2003, 9(S1):S3–S13.

Hay J. "Hospital Cost Drivers: An Evaluation of 1998–2001 State–Level Data." American Journal of Managed Care. 2003, 9(S1):S14–S24.

Etemad L, Hay J. Cost Effectiveness Analysis of Pharmaceutical Care in a Medicare Drug Benefit Program. Value in Health. 2003, 6(4):425–435.

Hay J. Evaluating the Cost–Effectiveness of Statins. Journal of Managed Care Pharmacy. 2004 10(1): 569–71.

Chen L, Hay J. Cost–Effectiveness Of Implanted Cardioverter Defibrillator for Sudden Death Prevention in Congestive Heart Failure. In press, Journal of Cardiovascular Pharmacology and Therapeutics.

Hay J, Sterling K. "Cost Effectiveness Analysis of Fibrates for Dyslipidemia." In press, Pharmacoeconomics.

Dwight–Johnson M, Largomarsino I, Aisenberg E, Hay J. Understanding Depression Treatment Preferences among Low–Income Latinos using Conjoint Analysis. In press, Psychiatric Services.

Kathleen Johnson

Purdum, A, Johnson KA, Globe D. Costs and Outcomes of HIV Patients in a Managed Care Setting. In Press AIDS Care. 2003.

Globe D, Johnson KA, Conant L, Frausto, S. Service Learning in Public Health and Management Courses. In Press, American Journal Pharmaceutial Education. 2003.

Johnson KA and Farris, Karen: "Data Management in Pharmaceutical Care", in Patient Centered Pharmacy Management. Harry Hagel, John Rovers, editors. APhA Press. Washington D.C., 2002.

Oh, Yongtae, McCombs JS, Cheng, RA, Johnson, KA. Pharmacist's Time Requirements for Counseling in an Outpatient Pharmacy. AJHP 59:2346–2355, December 2002.

Venturini F and Johnson KA. Application of Pharmacoeconomic Principles in Pharmacy Practice. California Journal of Health System Pharmacy. Vol 14(1)6–14. January/February 2002.

Jeff McCombs

Yong Y, Hay JW and McCombs JS. Mortality and hospitalization impacts of pharmacy consultation in ambulatory care. Am J Manage Care 9(1):101–112, January 2003.

Parker JP, McCombs JS and Graddy E. Can pharmacy data improve prediction of hospital outcomes? Comparisons with a diagnosis–based comorbidity measure. Medical Care 41(3):407–419, March 2003.

McCombs JS, Shi L, Croghan TW and Stimmel GL. Access to drug therapy and substitution between alternative antidepressants following an expansion of the California Medicaid formulary. Health Policy 65:301–311, 2003.

McCombs JS, Mulani P and Gibson JP: Open access to innovative drugs: Treatment substitutions or treatment expansion? Health Care Financing Review 2004 (Spring 2004).

McCombs JS, Thiebaud P, McLaughlin–Miley C and Shi J. Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas (forthcoming).

Shi L, Thiebaud P and McCombs JS.: The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee–for–service California Medicaid (Medi–Cal) program. In press, Journal of Affective Disorders Fall 2003, revised Feb. 2004.

Mike Nichol

van de Putte LBA, Nichol MB. Humira (adalimumab) for rheumatoid arthritis: Considerations for reimbursement by third–party payors. Disease Management and Health Outcomes, 12:1–8, 2004.

Sullivan PW, Follin S, Nichol MB. The societal costs and benefits associated with the use of first generation antihistamines in patients with allergic rhinitis Pharmacoeconomics, 2003 (in press)

Sullivan PW and Nichol MB. The economic impact of payer policies after the Rx–to–OTC switch of second–generation antihistamines. Value in Health, 2003 (in press)

Shi CW, Asch SM, Fielder E, Gelberg L, Nichol MB. Consumer knowledge of over–the–counter phenazopyridine. Annals of Family Medicine, 2003 (in press)

Sullivan PW, Follin S, Nichol MB. Transitioning the non sedating antihistamines to over–the–counter status: A cost–effectiveness analysis. Medical Care, 41(12):1382–1395, 2003.

Shi CW, Asch SM, Fielder E, Gelberg L, Nichol MB. Usage patterns of over–the–counter phenazopyridine (Pyridium). Journal of General Internal Medicine, 18:1–7, 2003.

Burk C, Gilderman A, Salas J, Berenbeim D, Nichol MB. The impact of an over–the–counter migraine medication program on patient health–related quality of life outcomes. Headache, 43: 191–2001, 2003.

Jones, J, Stahl D, Nichol MB, Azen SP. Enabling clinically based knowledge discovery in pharmacy claims data: An application in bioinformatics, Journal of Japanese Society of Computing and Statistics (JJSCS), 15:39–47, 2003.